Eligibility criteria
Condition
Pneumococcal Infections
Sex
Females and Males
Age
50-85 years
Inclusion criteria
Show details
- Stage 1: Healthy male or female adults 50 to 64 years of age with no history of
pneumococcal vaccination
- Stage 2: Healthy male or female adults 65 to 85 years of age previously vaccinated
with Prevnar 13 >= 2 months prior to investigational product administration
Exclusion criteria
Show details
- Stage 1: Vaccination within 12 months before investigational product administration
with diphtheria-, pertussis-, or tetanus-containing vaccine
- Stage 2: Previous vaccination with any pneumococcal vaccine other than a single prior
dose of Prevnar 13